1 / 20

What is the most likely outcome of erythropoietin therapy in a woman with early-stage chronic kidney disease and anemia?

?

Increased ventricular hypertrophy

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy